SCI Abstract

search
+
Modern Management of Gastric Neuroendocrine Neoplasms
Modern Management of Gastric Neuroendocrine Neoplasms
Gastric neuroendocrine neoplasms (G-NENs) are a heterogeneous group of tumors that broadly fall into two groups. The first...
Advancements in Melanoma Therapies: From Surgery to Immunotherapy
Advancements in Melanoma Therapies: From Surgery to Immunotherapy
Melanoma is defined as the most aggressive and deadly form of skin cancer. The treatment of melanoma depends on the&nb...
Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review
Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review
Anthracycline (ANT)-induced cardiotoxicity (AIC) is a particularly prominent form of cancer therapy-related cardiovascular...
Small Cell Lung Cancer—An Update on Chemotherapy Resistance
Small Cell Lung Cancer—An Update on Chemotherapy Resistance
Compared to other types of lung cancer, small cell lung cancer (SCLC) exhibits aggressive characteristics that promote dru...
Cardiovascular Considerations in Patients Undergoing Hematopoietic Cell Transplantation
Cardiovascular Considerations in Patients Undergoing Hematopoietic Cell Transplantation
Cardiac dysfunction is a serious adverse effect of cancer therapies that can interfere with quality of life and impact lon...
Recent Advances in Immunotherapy for Advanced Biliary Tract Cancer
Recent Advances in Immunotherapy for Advanced Biliary Tract Cancer
Biliary tract cancer (BTC) is a heterogeneous group of aggressive malignancies that arise from the epithelium of the bilia...
Opportunities and Challenges in Soft Tissue Sarcoma Risk Stratification in the Era of Personalised Medicine
Opportunities and Challenges in Soft Tissue Sarcoma Risk Stratification in the Era of Personalised Medicine
Soft tissue sarcomas (STS) are a rare and heterogeneous group of cancers. Treatment options have changed little in the pas...
Gastrointestinal Cancer Therapy and Cardiotoxicity
Gastrointestinal Cancer Therapy and Cardiotoxicity
Gastrointestinal cancers are a heterogenous group of cancers that share common risk factors with cardiovascular disease. T...
Management Approaches for High-Risk Cutaneous Squamous Cell Carcinoma with Perineural Invasion: An Updated Review
Management Approaches for High-Risk Cutaneous Squamous Cell Carcinoma with Perineural Invasion: An Updated Review
Cutaneous squamous cell carcinoma (cSCC) stands as the second most prevalent non-melanoma skin cancer worldwide, comprisin...
Current status of Complementary and Alternative Medicine Interventions in the Management of Pancreatic Cancer – An Overview
Current status of Complementary and Alternative Medicine Interventions in the Management of Pancreatic Cancer – An Overview
Pancreatic cancer (PC) remains the deadliest cancer worldwide. Most patients are diagnosed at the advanced or metastatic s...
Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Clinical Relevance, Impact on Outcome, Preventive Measures and Treatment Strategies
Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Clinical Relevance, Impact on Outcome, Preventive Measures and Treatment Strategies
The introduction of TKIs into the therapeutic armamentarium of CML has changed the disease paradigm, increasing long-term ...
The Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective
The Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective
Given the considerable heterogeneity in neuroendocrine neoplasms (NENs), it appears unlikely that a sole biomarker exists ...
Updates in Management of Malignant Pleural Mesothelioma
Updates in Management of Malignant Pleural Mesothelioma
Malignant pleural mesothelioma (MPM) is an aggressive asbestos-associated thoracic malignancy that is usually incurable. A...
The Evolving Treatment Landscape of Medullary Thyroid Cancer
The Evolving Treatment Landscape of Medullary Thyroid Cancer
Genetic assessment is crucial to address the correct treatment for advanced medullary thyroid cancer (MTC). Multi tyrosine...
Application of Engineered Dendritic Cell Vaccines in Cancer Immunotherapy: Challenges and Opportunities
Application of Engineered Dendritic Cell Vaccines in Cancer Immunotherapy: Challenges and Opportunities
The primary objective of this study is to evaluate the effectiveness of cancer vaccines containing genetically modified de...
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer
Standard frontline treatment of metastatic colorectal cancer (CRC) is cytotoxic chemotherapy plus a biologic agent such as...
Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
Approximately 15–20% of breast cancers (BC) demonstrate HER2 overexpression/gene amplification. Historically, before...
Update of Diagnosis and Targeted Therapy for ALK+ Inflammation Myofibroblastic Tumor
Update of Diagnosis and Targeted Therapy for ALK+ Inflammation Myofibroblastic Tumor
Inflammatory myofibroblastic tumor (IMT), characterized by intermediate malignancy and a propensity for recurrence, has pr...
Frontiers of Ovarian Carcinosarcoma
Frontiers of Ovarian Carcinosarcoma
Ovarian carcinosarcoma (OCS), also known as a malignant mixed Müllerian tumour (MMMT), is a rare and aggressive form ...
The Role of Liver Transplantation in the Treatment of Liver Metastases from Neuroendocrine Tumors
The Role of Liver Transplantation in the Treatment of Liver Metastases from Neuroendocrine Tumors
Transplant oncology is a new field of medicine referred to the use of solid organ transplantation, particularly the liver,...
Developing Strategies to Improve the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia
Developing Strategies to Improve the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a fatal blood malignancy. With the development of immunotherapy, particularly chimeric ant...
Systemic Therapy in Advanced Pleomorphic Liposarcoma: a Comprehensive Review
Systemic Therapy in Advanced Pleomorphic Liposarcoma: a Comprehensive Review
The therapeutic approach of pleomorphic liposarcoma (PLPS), a rare high-grade subgroup of soft tissue sarcoma, is commonly...
Sequencing Systemic Therapy in Hepatocellular Carcinoma
Sequencing Systemic Therapy in Hepatocellular Carcinoma
Multiple treatment options are now approved for unresectable hepatocellular carcinoma (HCC). An immune checkpoint inhibito...
Correction to: Update on Immunotherapy Cardiotoxicity: Checkpoint Inhibitors, CAR T, and Beyond
Correction to: Update on Immunotherapy Cardiotoxicity: Checkpoint Inhibitors, CAR T, and Beyond
Cite this articlePatel, M., Hudson, O., Han, J. et al. Correction to: Update on Immunotherapy Cardiotoxicity: Checkpoint I...
Optimal Therapeutic Strategy for PD-L1 Negative Metastatic Non-Small Cell Lung Cancer: A Decision-Making Guide Based on Clinicopathological and Molecular Features
Optimal Therapeutic Strategy for PD-L1 Negative Metastatic Non-Small Cell Lung Cancer: A Decision-Making Guide Based on Clinicopathological and Molecular Features
Strategies using immune checkpoint inhibitors (ICI), which can enhance antitumor immune responses, have revolutionized the...
Radiotherapy for Advanced Esophageal Cancer: from Palliation to Curation
Radiotherapy for Advanced Esophageal Cancer: from Palliation to Curation
Esophageal cancer is a global health problem, which is 7th most common and 6th most deadly cancer. It has been the era of ...
Correction to: Voluntary Assisted Dying/Euthanasia: Will This Have an Impact on Cancer Care in Future Years?
Correction to: Voluntary Assisted Dying/Euthanasia: Will This Have an Impact on Cancer Care in Future Years?
Department of Medicine, University of Melbourne, Victoria Pde, Fitzroy, Melbourne, Victoria, 3065, AustraliaJennifer Phili...
Mitigating Radiotoxicity in the Central Nervous System: Role of Proton Therapy
Mitigating Radiotoxicity in the Central Nervous System: Role of Proton Therapy
Central nervous system (CNS) radiotoxicity remains a challenge in neuro-oncology. Dose distribution advantages of protons ...
The Crying Need for a Better Response Assessment in Rectal Cancer
The Crying Need for a Better Response Assessment in Rectal Cancer
Since total neoadjuvant treatment achieves almost 30% pathologic complete response, organ preservation has been increasing...
Opioid-induced Neurotoxicity in Patients with Cancer Pain
Opioid-induced Neurotoxicity in Patients with Cancer Pain
Opioid-induced neurotoxicity (OINT) is a neuropsychiatric syndrome observed with opioid therapy. The mechanism of OINT is ...
Load More
format_indent_increase